The National Institute of Allergy and Infectious Diseases (NIAID) Centers of Excellence for Influenza Research and Surveillance (CEIRS) program is a multidisciplinary and collaborative network of research centers. Investigators perform surveillance integrated with research on host immune response, viral pathogenesis, and the factors that control the emergence and transmission of influenza viruses. The overall goal of the CEIRS Network is to provide the information and public health tools needed to control the impact of epidemic influenza and the threat of pandemic influenza.

COVID-19 Blood Plasma Clinical Trials
JHCEIRS Investigators Receive Federal Funding for Nationwide Study
Drs. Andrew Pekosz and Sabra Klein are part of a collaboration at Johns Hopkins University that will evaluate the effectiveness of convalescent blood plasma therapy against SARS-CoV-2 infection.

CEIRS Generated Reagents
Connecting Researchers to Influenza Reagents
The CEIRS Reagents webpage is a searchable and filterable catalog of over 5,000 unique, influenza-specific reagents developed by CEIRS researchers. These reagents (plasmids, proteins, antibodies, and viruses) are available to the broader scientific community and can be requested through the CEIRS Reagents webpage.

The CEIRS Network
A Program of the National Institute of Allergy and Infectious Diseases
Due to the ever present threat of an influenza pandemic, the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) program was established to support the research agenda of the HHS Pandemic Influenza Plan.


Capturing the Flu in Colombia with Dr. Dib
Juan C. Dib, MD, MPH/TM, PhD, discusses his career as a multidisciplinary scientist and physician working with indigenous peoples to study influenza and other tropical infectious diseases.

Improving Influenza Vaccines
CEIRS Trainee Spotlight featuring Teddy John Wohlbold
Mr. Teddy John Wohlbold shares his experience with the CEIRS Training Program and his work on refining antibody responses to the flu.

B-cells, Boosters, and Precision Vaccines
David Topham, PhD, co-Principal Investigator of the New York Influenza Center of Excellence (NYICE), discusses the relationship between an individual’s immune response and seasonal flu viruses and a translational approach to influenza research.
Latest News
- Dr. Benjamin Miller’s Research Chosen as Editors’ Choice by ACS Publications
- CEIRS Network Collaboratively Performs Risk Assessment for Emerging Canine H3 Influenza Viruses: Lessons Learned for Future Pandemic Response
- CRIP Researcher Publishes Collaborative Study on SARS-CoV-2 Variant